Centre for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast, Belfast, UK.
BMC Immunol. 2018 Jul 11;19(1):24. doi: 10.1186/s12865-018-0261-0.
Macrophages are tissue resident immune cells important for host defence and homeostasis. During diabetes, macrophages and other innate immune cells are known to have a pro-inflammatory phenotype, which is believed to contribute to the pathogenesis of various diabetic complications. However, diabetic patients are highly susceptible to bacterial infections, and often have impaired wound healing. The molecular mechanism underlying the paradox of macrophage function in diabetes is not fully understood. Recent evidence suggests that macrophage functions are governed by metabolic reprograming. Diabetes is a disorder that affects glucose metabolism; dysregulated macrophage function in diabetes may be related to alterations in their metabolic pathways. In this study, we seek to understand the effect of high glucose exposure on macrophage phenotype and functions.
Bone marrow cells were cultured in short or long term high glucose and normal glucose medium; the number and phenotype of bone marrow derived macrophages were not affected by long-term high glucose treatment. Short-term high glucose increased the expression of IL-1β. Long-term high glucose increased the expression of IL-1β and TNFα but reduced the expression of IL-12p40 and nitric oxide production in M1 macrophage. The treatment also increased Arg-1 and IL-10 expression in M2 macrophages. Phagocytosis and bactericidal activity was reduced in long-term high glucose treated macrophages and peritoneal macrophages from diabetic mice. Long-term high glucose treatment reduced macrophage glycolytic capacity and glycolytic reserve without affecting mitochondrial ATP production and oxidative respiration.
Long-term high glucose sensitizes macrophages to cytokine stimulation and reduces phagocytosis and nitric oxide production, which may be related to impaired glycolytic capacity.
巨噬细胞是组织驻留免疫细胞,对宿主防御和稳态至关重要。在糖尿病中,已知巨噬细胞和其他固有免疫细胞具有促炎表型,这被认为有助于各种糖尿病并发症的发病机制。然而,糖尿病患者极易发生细菌感染,并且经常存在伤口愈合受损的情况。巨噬细胞在糖尿病中的功能的这种矛盾现象的分子机制尚未完全阐明。最近的证据表明,巨噬细胞的功能受代谢重编程的控制。糖尿病是一种影响葡萄糖代谢的疾病;糖尿病中巨噬细胞功能的失调可能与它们的代谢途径的改变有关。在这项研究中,我们试图了解高葡萄糖暴露对巨噬细胞表型和功能的影响。
骨髓细胞在短期或长期高葡萄糖和正常葡萄糖培养基中培养;长期高葡萄糖处理对骨髓来源的巨噬细胞的数量和表型没有影响。短期高葡萄糖增加了 IL-1β 的表达。长期高葡萄糖增加了 IL-1β 和 TNFα 的表达,但降低了 M1 巨噬细胞中 IL-12p40 的表达和一氧化氮的产生。该处理还增加了 M2 巨噬细胞中 Arg-1 和 IL-10 的表达。长期高葡萄糖处理的巨噬细胞和糖尿病小鼠的腹腔巨噬细胞的吞噬作用和杀菌活性降低。长期高葡萄糖处理降低了巨噬细胞的糖酵解能力和糖酵解储备,而不影响线粒体 ATP 产生和氧化呼吸。
长期高葡萄糖使巨噬细胞对细胞因子刺激敏感,并降低吞噬作用和一氧化氮的产生,这可能与糖酵解能力受损有关。